Literature DB >> 9924600

The relationship between opioid use and laxative use in terminally ill cancer patients.

N P Sykes1.   

Abstract

The frequency of the use of laxatives, and the relationship between doses of laxatives and of opioid analgesia, were determined by a prospective study of 498 hospice inpatients with advanced cancer. Laxatives were required by 87% of patients taking oral strong opioids, 74% of those on weak opioids and 64% of those not receiving opioid analgesia. The form of the relationship appears to be hyperbolic, as suggested by the presentation of the results arranged by opioid quartile and by the improved correlation obtained by subjecting the opioid data to a logarithmic transformation. It is concluded that opioids account for about a quarter of the constipation found in terminally ill cancer patients in a hospice. However, the dose of laxative required is likely to be significantly higher if an opioid is being taken than if not. The form of the relationship between laxative and strong opioid doses is what might be expected from the mediation of opioid-induced constipation by opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924600     DOI: 10.1191/026921698674125048

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  34 in total

1.  Effectiveness of laxatives in adults.

Authors:  M Petticrew; M Rodgers; A Booth
Journal:  Qual Health Care       Date:  2001-12

2.  [Strong opioids and constipation].

Authors:  A Schwarzer; F Nauck; E Klaschik
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

3.  Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database.

Authors:  Lars Morten Skollerud; Olav Ms Fredheim; Kristian Svendsen; Svetlana Skurtveit; Petter C Borchgrevink
Journal:  Support Care Cancer       Date:  2012-06-01       Impact factor: 3.603

4.  Cancer constipation: are opioids really the culprit?

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

5.  How safe and effective is methylnaltrexone for the treatment of opioid-induced constipation in advanced illness?

Authors:  Joseph Foss
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-18

6.  Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec.

Authors:  R E Williams; N Bosnic; C T Sweeney; A W Duncan; K B Levine; M Brogan; S F Cook
Journal:  Pain Res Manag       Date:  2008 Sep-Oct       Impact factor: 3.037

Review 7.  Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model.

Authors:  Amy P Abernethy; Jane L Wheeler; S Yousuf Zafar
Journal:  Curr Opin Support Palliat Care       Date:  2010-03       Impact factor: 2.302

Review 8.  [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].

Authors:  Jürgen Osterbrink; Ute Haas
Journal:  Wien Med Wochenschr       Date:  2008

9.  A 73-year-old man with long-term immobility presenting with abdominal pain.

Authors:  Salomone Di Saverio; Gregorio Tugnoli; Paolo Emilio Orlandi; Marco Casali; Fausto Catena; Andrea Biscardi; Omeshnie Pillay; Franco Baldoni
Journal:  PLoS Med       Date:  2009-07-14       Impact factor: 11.069

10.  Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.

Authors:  Peter Deibert; Carola Xander; Hubert E Blum; Gerhild Becker
Journal:  Core Evid       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.